Alpha 2.0
Login Register
» Authors » Iman Ragab

Iman Ragab

Explore the profile of Iman Ragab including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 130
Followers 0
Related Specialties
Oncology
Genetics
Pediatrics
Top 10 Co-Authors
Danuta Januszkiewicz-Lewandowska
Manon Suerink
Sara Makkeyah
Daniel Rueda
Amedeo A Azizi
Katharina Wimmer
Thorsten Rosenbaum
Daniel C Moreira
Muhammad Rafie Raza
Karin Dahan
Published In
J Saudi Heart Assoc
Front Immunol
Leuk Lymphoma
Glob Qual Nurs Res
Cancer Med
Affiliations
Soon will be listed here.
Recent Articles
1.
Immunodeficiency in children with Diamond Blackfan and Diamond Blackfan like anemia
Ragab I, Makkeyah S, Hassan N, Botros M, Da Costa L, Aly N
Blood Cells Mol Dis . 2025 Feb; 111:102911. PMID: 39923319
Background: Diamond-Blackfan anemia Syndrome (DBAS) is a ribosomopathy with erythroid failure. DBA-like picture occurs with non-ribosomal mutation and a normal rRNA maturation. Immunodeficiency in patients with DBAS is not adequately...
2.
ELMO2-related intraosseous vascular malformation: new cases with novel pathogenic variants, clinical follow-up and therapeutic approaches
Karakaya M, Ragab I, Riehmer V, Erger F, Aly N, Ryu S, et al.
Eur J Hum Genet . 2024 Dec; 33(3):334-343. PMID: 39627357
Primary intraosseous vascular malformation (VMPI, #606893) is an ultra-rare disorder caused by biallelic pathogenic variants in ELMO2. To date, only six families with pathogenic ELMO2 variants causing a VMPI phenotype...
3.
Egyptian Pediatric Guidelines for the Management of Children with Isolated Thrombocytopenia Using the Adapted ADAPTE Methodology-A Limited-Resource Country Perspective
Mokhtar G, Abdelbaky A, Adly A, Ezzat D, Abdel Hakeem G, Hassab H, et al.
Children (Basel) . 2024 Apr; 11(4). PMID: 38671669
Background: Thrombocytopenia is a prevalent presentation in childhood with a broad spectrum of etiologies, associated findings, and clinical outcomes. Establishing the cause of thrombocytopenia and its proper management have obvious...
4.
Transfusion of blood components in pediatric age groups: an evidence-based clinical practice guideline adapted for the use in Egypt using 'Adapted ADAPTE'
Mokhtar G, Adly A, Abdel Baky A, Ezzat D, Abdel Hakeem G, Hassab H, et al.
Ann Hematol . 2024 Feb; 103(4):1373-1388. PMID: 38388746
Pediatric transfusion is a complex area of medicine covering a wide age range, from neonates to young adults. Compared to adult practice, there is a relative lack of high-quality research...
5.
Communication transforms the impact of the COVID-19 pandemic on children with cancer and their families
Ferrara G, Aguina M, Mirochnick E, Wiphatphumiprates P, Moreira D, Sniderman E, et al.
Cancer Med . 2023 Apr; 12(11):12813-12826. PMID: 37081718
Background: The COVID-19 pandemic altered healthcare systems globally, causing delays in care delivery and increased anxiety among patients and families. This study examined how hospital stakeholders and clinicians perceived the...
6.
Constitutional Microsatellite Instability, Genotype, and Phenotype Correlations in Constitutional Mismatch Repair Deficiency
Gallon R, Phelps R, Hayes C, Brugieres L, Guerrini-Rousseau L, Colas C, et al.
Gastroenterology . 2022 Dec; 164(4):579-592.e8. PMID: 36586540
Background & Aims: Constitutional mismatch repair deficiency (CMMRD) is a rare recessive childhood cancer predisposition syndrome caused by germline mismatch repair variants. Constitutional microsatellite instability (cMSI) is a CMMRD diagnostic...
7.
Effects of COVID-19 on Pediatric Cancer Care: A Multicenter Study of 11 Middle Eastern Countries
Elzembely M, Al Rawas A, Al-Hebshi A, Alhadi A, Ibrahim A, Zein A, et al.
J Pediatr Hematol Oncol . 2022 Oct; 45(1):e87-e91. PMID: 36219708
During the COVID-19 pandemic, major challenges are facing pediatric cancer centers regarding access to cancer centers, continuity of the anti-cancer therapy, hospital admission, and infection protection precautions. Pediatric oncologists actively...
8.
Utilizing Multilingual Methods and Rapid Analysis for Global Qualitative Research During a Pandemic
Graetz D, Sniderman E, Villegas C, Ragab I, Laptsevich A, Maliti B, et al.
Glob Qual Nurs Res . 2022 Mar; 9:23333936221080969. PMID: 35237707
Historically, qualitative research has complemented quantitative biologic and epidemiologic studies to provide a more complete understanding of pandemics. The COVID-19 pandemic has generated unique and novel challenges for qualitative researchers,...
9.
Resilient health care in global pediatric oncology during the COVID-19 pandemic
Graetz D, Sniderman E, Villegas C, Kaye E, Ragab I, Laptsevich A, et al.
Cancer . 2021 Nov; 128(4):797-807. PMID: 34767629
Background: In the face of unprecedented challenges because of coronavirus disease 2019, interdisciplinary pediatric oncology teams have developed strategies to continue providing high-quality cancer care. This study explored factors contributing...
10.
Treatment outcomes for childhood acute lymphoblastic leukemia in low-middle income country before minimal residual disease risk stratification
Makkeyah S, Manzour A, Tantawy A, Mohamed A, Ebeid F, El-Sherif N, et al.
Cancer Epidemiol . 2021 Oct; 75:102040. PMID: 34649157
Background: Outcome of childhood acute lymphoblastic leukemia (ALL) in low- and middle-income countries is lagging in many aspects including diagnosis, risk stratification, access to treatment and supportive care. Objective: to...